Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking method to diabetes management. These innovative therapies function by mimicking the physiological actions of GLP-1, a hormone produced by https://lucywzpt120249.elbloglibre.com/39188665/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes